QLGN
XNAS
$1.26
Qualigen Therapeutics, Inc. Common Stock (QLGN)
Sector:
Healthcare
Industry:
Biotechnology
Market Cap
$2.09M
P/B Ratio
0.05
Price Chart
Valuation
Market Cap$2.09M
P/S1.12
P/B0.05
Profitability
EBITDA-$7.17M
Profit Margin-38.2%
Operating Margin-59.6%
EPS-$2.82
Financial Health
Debt-to-Equity8.4%
Growth & Risk
Sharpe Ratio-0.20